News Coherus BioSciences, Inc.

Equities

CHRS

US19249H1032

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
2 ^USD	-6.98%		-17.01%	-39.94%

Mar. 20	HC Wainwright Adjusts Coherus BioSciences' Price Target to $11 From $13, Keeps Buy Rating	MT
Mar. 14	Coherus BioSciences Shares Fall After Workforce Reduction Plan; Q4 Loss	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting	Apr. 08	GL
HC Wainwright Adjusts Coherus BioSciences' Price Target to $11 From $13, Keeps Buy Rating	Mar. 20	MT
Coherus BioSciences Shares Fall After Workforce Reduction Plan; Q4 Loss	Mar. 14	MT
Transcript : Coherus BioSciences, Inc., Q4 2023 Earnings Call, Mar 13, 2024	Mar. 13
Coherus BioSciences: Q4 Earnings Snapshot	Mar. 13	AQ
Earnings Flash (CHRS) COHERUS BIOSCIENCES Reports Q4 Revenue $91.5M, vs. Street Est of $90.4M	Mar. 13	MT
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update	Mar. 13	GL
Coherus BioSciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 13	CI
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	Mar. 07	AQ
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024	Mar. 05	GL
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024	Mar. 05	AQ
North American Morning Briefing : Stock Futures -2-	Mar. 04	DJ
North American Morning Briefing : Stock Futures Hover At Start of Busy Week	Mar. 04	DJ
Coherus BioSciences Completes $170 Million Sale of Ophthalmology Franchise to Sandoz	Mar. 04	MT
Sandoz: acquisition of Cimerli finalized	Mar. 04	CF
Sandoz Completes Purchase of Retinal Disease Medication Cimerli from Coherus BioSciences	Mar. 04	MT
Coherus Completes Divestiture of Ophthalmology Franchise	Mar. 04	GL
Coherus Completes Divestiture of Ophthalmology Franchise	Mar. 04	AQ
Sandoz Inc. completed the acquisition of CIMERLI an ophthalmology franchise from Coherus BioSciences, Inc..	Feb. 29	CI
Coherus BioSciences Announces New Employment Inducement Grants	Feb. 26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Coherus BioSciences, Inc.

Equities

CHRS

US19249H1032

Summary

Filters